{"nctId":"NCT00838201","briefTitle":"Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer","startDateStruct":{"date":"2009-02-01","type":"ACTUAL"},"conditions":["Cancer","Carcinoma","Castrate-Resistant Prostate Cancer","Prostate Cancer","Tumors"],"count":384,"armGroups":[{"label":"Arm 1","type":"EXPERIMENTAL","interventionNames":["Drug: Denosumab"]}],"interventions":[{"name":"Denosumab","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects must be currently participating in the 20040138 Amgen study\n* Subjects must sign the informed consent before any study specific procedures are performed.\n\nExclusion Criteria\n\n* Subjects with any prior diagnosis of bone metastasis\n* Known hypocalcemia\n* Developed sensitivity to mammalian cell derived drug products during the 20040138 study\n* Currently receiving any investigational product other than denosumab or having received any investigational product during the 20040138 study\n* Any disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent and/or comply with study procedures","healthyVolunteers":false,"sex":"MALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Overall Survival Through Month 24","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"174","spread":null},{"groupId":"OG001","value":"184","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":45,"n":185},"commonTop":["Constipation","Arthralgia","Pain in extremity","Nausea","Back pain"]}}}